<DOC>
	<DOCNO>NCT00627783</DOCNO>
	<brief_summary>DYNAMIT prospective , randomize , multicenter , open strategy trial run 45 French hospital . Diabetic patient evidence coronary artery disease least 2 additional cardiovascular risk factor randomize screen silent ischemia use bicycle exercise test Dipyridamole Single Photon Emission Computed Tomography ( N=316 ) , follow-up without screen ( N=315 ) . All access cardiovascular prevention accord current guideline . The main end point time death cause , non-fatal myocardial infarction , non-fatal stroke , heart failure require hospitalization emergency service intervention .</brief_summary>
	<brief_title>Do You Need Assess Myocardial Ischemia Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<criteria>Patients 55 75 year old type2 diabetes least two follow cardiovascular risk factor : urinary albumin excretion &gt; 30 mg/L &gt; 30 mg/24 hour , treat untreated hypertension , treat untreated lipid abnormality , peripheral arterial disease , history transient ischemic accident , tobacco consumption familial history premature cardiovascular disease . History myocardial infarction , coronary artery disease , stroke , Previous positive stress test myocardial perfusion imaging , Negative stress test myocardial perfusion image within last three year</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2008</verification_date>
</DOC>